A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Initially Mimicking Cutaneous Lupus Erythematosus
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease. The prognosis is poor in most cases with rapid progression despite administering chemotherapy. A 67-yearold man complained of skin rashes on his back and this spread to the trunk, face, arms and thighs, and he was initially diagnosed with cutaneous lupus erythematosus according to the skin biopsy. The skin rashes then became aggravated on a trial of low dose methylprednisolone for 3 months. Repeated skin biopsy revealed a diffuse infiltration of lymphoid cells with medium sized nuclei, positive for CD4 and CD56, negative for Epstein-Barr virus (EBV), indicating a diagnosis of BPDCN. Further workups confirmed stage IVA BPDCN involving the skin, multiple lymph nodes, the peripheral blood and the bone marrow. He was treated with six cycles of combination chemotherapy consisting of ifosphamide, methotrexate,etoposide, prednisolone and L-asparaginase, and he achieved a partial response. Herein we report on a rare case of BPDCN that was initially misinterpreted as cutaneous lupus erythematosus.
Abstract
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease. The prognosis is poor in most cases with rapid progression despite administering chemotherapy. A 67-yearold man complained of skin rashes on his back and this spread to the trunk, face, arms and thighs, and he was initially diagnosed with cutaneous lupus erythematosus according to the skin biopsy. The skin rashes then became aggravated on a trial of low dose methylprednisolone for 3 months. Repeated skin biopsy revealed a diffuse infiltration of lymphoid cells with medium sized nuclei, positive for CD4 and CD56, negative for Epstein-Barr virus (EBV), indicating a diagnosis of BPDCN. Further workups confirmed stage IVA BPDCN involving the skin, multiple lymph nodes, the peripheral blood and the bone marrow. He was treated with six cycles of combination chemotherapy consisting of ifosphamide, methotrexate,etoposide, prednisolone and L-asparaginase, and he achieved a partial response. Herein we report on a rare case of BPDCN that was initially misinterpreted as cutaneous lupus erythematosus.
참고문헌 (15)
- Adachi M, "High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma", Am J Hematol, 47, pp.278~282 (1994)
- Bueno C, "Incidence and characteristics of CD4(+)", HLA DRhi dendritic cell malignancies, 2004, pp.89, 58~69
- Oshimi K, "NK-cell neoplasms in Japan", Hematology, 10, pp.237~245 (2005)
- Kim Yoonjung, "CD4+CD56+ Lineage Negative Hematopoietic Neoplasm: So Called Blastic NK Cell Lymphoma", Journal of Korean Medical Science, 20(2), pp.319~324 (2005), 대한의학회
- Lee M, "Clinicopathologic and genetic study of cutaneous blastic NK lymphoma in Korea", Korean Journal of Dermatology, 45, pp.145~ (2007)
- Petrella T, "CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC)", Am J Surg Pathol, 23, pp.137~146 (1999)
- Willemze R, "WHO-EORTC classification for cutaneous lymphomas", Blood, 105, pp.3768~3785 (2005)
- Chaperot L, "Identification of a leukemic counterpart of the plasmacytoid dendritic cells", Blood, 97, pp.3210~3217 (2001)
- Jaye DL, "Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms", Mod Pathol, 19, pp.1555~1562 (2006)
- Cota C, "Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients", Am J Surg Pathol, 34, pp.75~87 (2010)
- Rönnblom L, "The innate immune system in SLE: type I interferons and dendritic cells", Lupus, 17, pp.394~399 (2008)
- Jegalian AG, "Plasmacytoid dendritic cells: physiologic roles and pathologic states", Adv Anat Pathol, 16, pp.392~404 (2009)
- Vermi W, "Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage", Immunobiology, 214, pp.877~886 (2009)
- Leitenberger JJ, "CD4+ CD56+ hematodermic", plasmacytoid dendritic cell tumor with response to pralatrexate, 2008, pp.58, 480~484
- Dalle S, "Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice", Br J Dermatol, 162, pp.74~79 (2010)